Dr. Christopher Spearman at Scott & Christie Eyecare Associates Becomes One of the First Five Eye Surgeons in United States to Offer New Glaukos iPRIME System

Scott and Christie Eyecare Associates is proud to share that Dr. Christopher Spearman has been selected as one of the first five doctors throughout the United States to utilize the Glaukos iPrime Viscodelivery System, a device which allows surgeons to help patients get better control of their glaucoma and reduce dependence on eye drops.

The sterile, single-use, minimally invasive device improves the delivery of viscoelastic fluid throughout the eye during surgery and was approved by the FDA earlier this year.

“I am honored and grateful to have been one of the first few surgeons selected to utilize the new iPrime technology for our patients throughout Pittsburgh and Western Pennsylvania,” said Dr. Christopher Spearman at Scott and Christie Eyecare Associates. “Scott and Christie Eyecare Associates is known for being one of the top clinical research sites in the world for new ophthalmic pharmaceuticals and devices. This is yet another example of how our team constantly works with the top innovators in our field to bring our patients the most positive and effective eye surgery experience possible.”